nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Bayesian basket trial design using a calibrated Bayesian hierarchical model
|
Chu, Yiyi |
|
2018 |
|
2 |
p. 149-158 |
artikel |
2 |
A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug
|
Berry, Scott M |
|
2010 |
|
2 |
p. 121-135 |
artikel |
3 |
A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials
|
Odani, Motoi |
|
2017 |
|
2 |
p. 192-200 |
artikel |
4 |
Abstracts
|
|
|
2004 |
|
2 |
p. 209-258 |
artikel |
5 |
Abstracts from the Society for Clinical Trials Annual Meeting, Boston, Massachusetts, USA - May 19-22, 2013
|
|
|
2013 |
|
2 |
p. S1-S88 |
artikel |
6 |
Academic chartered data safety committees versus industry sponsored data safety committees: The need for different recommendations
|
Weber, David J |
|
2018 |
|
2 |
p. 212-213 |
artikel |
7 |
A community consultation survey to evaluate support for and success of the IMMEDIATE trial
|
Beshansky, Joni R |
|
2014 |
|
2 |
p. 178-186 |
artikel |
8 |
A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome
|
Braschel, Melissa C |
|
2016 |
|
2 |
p. 180-187 |
artikel |
9 |
Adaptive dose insertion in early phase clinical trials
|
Hu, Bo |
|
2013 |
|
2 |
p. 216-224 |
artikel |
10 |
Adaptive parametric prediction of event times in clinical trials
|
Lan, Yu |
|
2018 |
|
2 |
p. 159-168 |
artikel |
11 |
A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome
|
Zhao, Yanli |
|
2007 |
|
2 |
p. 140-153 |
artikel |
12 |
Adherence reporting in randomized controlled trials
|
Zhang, Ze |
|
2014 |
|
2 |
p. 195-204 |
artikel |
13 |
Alignment of site versus adjudication committee–based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial
|
Sepehrvand, Nariman |
|
2016 |
|
2 |
p. 140-148 |
artikel |
14 |
A model for the design and implementation of a participant recruitment registry for clinical studies of older adults
|
Dowling, N Maritza |
|
2012 |
|
2 |
p. 204-214 |
artikel |
15 |
Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program
|
Roetzheim, Richard G |
|
2012 |
|
2 |
p. 176-187 |
artikel |
16 |
An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials
|
Mi, Michael Y |
|
2013 |
|
2 |
p. 207-215 |
artikel |
17 |
An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data
|
Tvete, Ingunn F |
|
2012 |
|
2 |
p. 164-175 |
artikel |
18 |
An embedded randomised controlled trial of a Teaser Campaign to optimise recruitment in primary care
|
Lee, Hopin |
|
2017 |
|
2 |
p. 162-169 |
artikel |
19 |
An evaluation of the effectiveness of recruitment methods: The staying well after depression randomized controlled trial
|
Krusche, Adele |
|
2014 |
|
2 |
p. 141-149 |
artikel |
20 |
An Institutional Review Board dilemma: responsible for safety monitoring but not in control
|
DeMets, David L |
|
2006 |
|
2 |
p. 142-148 |
artikel |
21 |
A note on masking in the SOX trial
|
Berger, Vance W |
|
2015 |
|
2 |
p. 177-177 |
artikel |
22 |
A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen
|
Fiore, Louis D |
|
2011 |
|
2 |
p. 183-195 |
artikel |
23 |
Apparent relationship between relative risk and control rate: statistical artifact or selection bias?
|
Weisberg, Herbert I |
|
2010 |
|
2 |
p. 118-119 |
artikel |
24 |
A practical look at cluster-randomized trials
|
Moulton, Lawrence H |
|
2005 |
|
2 |
p. 89-90 |
artikel |
25 |
A predictive probability design for phase II cancer clinical trials
|
Lee, J Jack |
|
2008 |
|
2 |
p. 93-106 |
artikel |
26 |
A randomized recruitment intervention trial in Parkinson’s disease to increase participant diversity: early stopping for lack of efficacy
|
Tilley, Barbara C |
|
2012 |
|
2 |
p. 188-197 |
artikel |
27 |
Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system
|
Zhao, Wenle |
|
2016 |
|
2 |
p. 223-233 |
artikel |
28 |
Are outcome-adaptive allocation trials ethical?
|
Hey, Spencer Phillips |
|
2015 |
|
2 |
p. 102-106 |
artikel |
29 |
Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials
|
Cooper, Cindy L |
|
2018 |
|
2 |
p. 189-196 |
artikel |
30 |
A review of the impact of utilising electronic medical records for clinical research recruitment
|
Lai, Yan See |
|
|
|
2 |
p. 194-203 |
artikel |
31 |
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
|
Blenkinsop, Alexandra |
|
|
|
2 |
p. 132-141 |
artikel |
32 |
Automated measurements for individualized heart rate correction of the QT interval
|
Mason, Jay W |
|
2015 |
|
2 |
p. 149-155 |
artikel |
33 |
Avoiding bias and incorrect confidence interval coverage in prescription drug labeling
|
Levin, Gregory |
|
2016 |
|
2 |
p. 199-204 |
artikel |
34 |
A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression
|
Durkalski, Valerie |
|
2010 |
|
2 |
p. 174-182 |
artikel |
35 |
Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders
|
Peay, Holly L |
|
2018 |
|
2 |
p. 139-148 |
artikel |
36 |
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
|
Quinlan, Judith |
|
2010 |
|
2 |
p. 167-173 |
artikel |
37 |
Bayesian models for subgroup analysis in clinical trials
|
Jones, Hayley E |
|
2011 |
|
2 |
p. 129-143 |
artikel |
38 |
Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study
|
Espeland, Mark A |
|
2006 |
|
2 |
p. 99-106 |
artikel |
39 |
Benefits and barriers to participating in longitudinal research of youth-onset type 2 diabetes: Results from the TODAY retention survey
|
Walders-Abramson, Natalie |
|
2016 |
|
2 |
p. 240-243 |
artikel |
40 |
Book Review: Design and analysis of clinical trials
|
Brannath, W |
|
2006 |
|
2 |
p. 158-159 |
artikel |
41 |
BookReview: Green S, Benedetti J and Crowley J 2003: Clinical trials in oncology. Second edition. Boca Raton: Chapman & Hall/CRC. 265 pp. US $79.95 (US $71.96 web price) (HB). ISBN 1 58488 302 2
|
Lombard, C.J. |
|
2004 |
|
2 |
p. 185-186 |
artikel |
42 |
BookReview: Jerry Menikoff and Edward P. Richards 2006: What the Doctor Didn't Say: The Hidden Truth about Medical Research. Oxford University Press. $34.99. ISBN-13 978-0-19-514797-1
|
Dixon, Dennis |
|
2009 |
|
2 |
p. 196-197 |
artikel |
43 |
Book Review: JM Gueron and H Rolston 2013: Fighting for reliable
|
Wittes, Janet Turk |
|
2014 |
|
2 |
p. 267-269 |
artikel |
44 |
Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand
|
Morin, Stephen F |
|
2008 |
|
2 |
p. 147-156 |
artikel |
45 |
Building trust and diversity in patient-centered oncology clinical trials: An integrated model
|
Hurd, Thelma C |
|
2017 |
|
2 |
p. 170-179 |
artikel |
46 |
Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study
|
Blumenthal, James A |
|
2009 |
|
2 |
p. 172-184 |
artikel |
47 |
Central site monitoring: Results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection
|
Lindblad, Anne S |
|
2014 |
|
2 |
p. 205-217 |
artikel |
48 |
Central statistical monitoring: Detecting fraud in clinical trials
|
Pogue, Janice M |
|
2013 |
|
2 |
p. 225-235 |
artikel |
49 |
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)
|
Schrag, Deborah |
|
|
|
2 |
p. 165-175 |
artikel |
50 |
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
|
Rosenheck, Robert A |
|
2011 |
|
2 |
p. 196-204 |
artikel |
51 |
Challenges in the research ethics review of cluster randomized trials: International survey of investigators
|
Chaudhry, Shazia H |
|
2013 |
|
2 |
p. 257-268 |
artikel |
52 |
Clinical trial designs for testing biomarker-based personalized therapies
|
Lai, Tze Leung |
|
2012 |
|
2 |
p. 141-154 |
artikel |
53 |
Clinician-trialist rounds: 9. Mentoring – part 3: the structure and function of effective mentoring: advice and protection
|
Straus, Sharon E |
|
2012 |
|
2 |
p. 272-274 |
artikel |
54 |
Clinician-trialist rounds: 3. Priority setting for academic success
|
Sackett, David L |
|
2011 |
|
2 |
p. 235-237 |
artikel |
55 |
Clinician-trialist rounds: 26. Sabbaticals. Part 1: Should I take a sabbatical?
|
Straus, Sharon E |
|
2015 |
|
2 |
p. 174-176 |
artikel |
56 |
Clinician-trialist rounds: 20. Shouldn’t ‘trialists-in-training’ rotate through RCT-clerkships?
|
Sackett, David L |
|
2014 |
|
2 |
p. 263-266 |
artikel |
57 |
Clinician-trialist rounds: 15. Ways to advance your career by saying ‘no’ – part 3: how to say ‘no’, nicely
|
Oxman, Andrew D |
|
2013 |
|
2 |
p. 340-343 |
artikel |
58 |
Commentary on Fleming et al.: Data monitoring committee evidence base needed
|
Terrin, Michael |
|
2017 |
|
2 |
p. 124-125 |
artikel |
59 |
Commentary on Hey and Kimmelman
|
Joffe, Steven |
|
2015 |
|
2 |
p. 116-118 |
artikel |
60 |
Commentary on Hey and Kimmelman
|
Korn, Edward L |
|
2015 |
|
2 |
p. 122-124 |
artikel |
61 |
Commentary on Hey and Kimmelman
|
Lee, J Jack |
|
2015 |
|
2 |
p. 110-112 |
artikel |
62 |
Commentary on Hey and Kimmelman
|
Buyse, Marc |
|
2015 |
|
2 |
p. 119-121 |
artikel |
63 |
Commentary on Hey and Kimmelman
|
Berry, Donald A |
|
2015 |
|
2 |
p. 107-109 |
artikel |
64 |
Commentary on Hey and Kimmelman
|
Saxman, Scott Brian |
|
2015 |
|
2 |
p. 113-115 |
artikel |
65 |
Commentary on Sertkaya et al. and Larson et al.
|
Eisenstein, Eric L |
|
2016 |
|
2 |
p. 137-139 |
artikel |
66 |
Comment on Vickers et al.
|
Chappell, Rick |
|
|
|
2 |
p. 214-215 |
artikel |
67 |
Comparison of characteristics and outcomes by initial study contact (website versus staff) for participants enrolled in a weight management study
|
Funk, Kristine L |
|
2012 |
|
2 |
p. 226-231 |
artikel |
68 |
Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials
|
Zhang, Zhiwei |
|
|
|
2 |
p. 122-131 |
artikel |
69 |
Conducting clinical trials—costs, impacts, and the value of clinical trials networks: A scoping review
|
Bentley, Colene |
|
|
|
2 |
p. 183-193 |
artikel |
70 |
Corrigendum
|
|
|
2017 |
|
2 |
p. 222 |
artikel |
71 |
Corrigendum
|
|
|
|
|
2 |
p. 219 |
artikel |
72 |
Corrigendum
|
|
|
2009 |
|
2 |
p. 198-198 |
artikel |
73 |
Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
|
Burton, Andrea |
|
2007 |
|
2 |
p. 154-161 |
artikel |
74 |
Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs
|
Moerbeek, Mirjam |
|
2018 |
|
2 |
p. 169-177 |
artikel |
75 |
Data and safety monitoring in social behavioral intervention trials: the REACH II experience
|
Czaja, Sara J |
|
2006 |
|
2 |
p. 107-118 |
artikel |
76 |
Data monitoring committees: Promoting best practices to address emerging challenges
|
Fleming, Thomas R |
|
2017 |
|
2 |
p. 115-123 |
artikel |
77 |
Delivering successful randomized controlled trials in surgery: Methods to optimize collaboration and study design
|
Blencowe, Natalie S |
|
2017 |
|
2 |
p. 211-218 |
artikel |
78 |
Design and analysis of clinical trials with clustering effects due to treatment
|
Roberts, Chris |
|
2005 |
|
2 |
p. 152-162 |
artikel |
79 |
Design and sample size considerations for Alzheimer’s disease prevention trials using multistate models
|
Brookmeyer, Ron |
|
|
|
2 |
p. 111-119 |
artikel |
80 |
Design of the Value of Imaging in Enhancing the Wellness of Your Heart (VIEW) trial and the impact of uncertainty on power
|
Ambrosius, Walter T |
|
2012 |
|
2 |
p. 232-246 |
artikel |
81 |
Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research
|
Campbell, Marion K |
|
2005 |
|
2 |
p. 99-107 |
artikel |
82 |
Developing targeted therapy
|
Siegel, Jay P. |
|
2007 |
|
2 |
p. 170-172 |
artikel |
83 |
Development of a checklist of quality indicators for clinical trials in resource-limited countries: The French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience
|
Hanna, Mina |
|
2013 |
|
2 |
p. 300-318 |
artikel |
84 |
Development of adherence metrics for caloric restriction interventions
|
Pieper, Carl |
|
2011 |
|
2 |
p. 155-164 |
artikel |
85 |
Differential recruitment in a cluster randomized trial in primary care: the experience of the UK Back pain, Exercise, Active management and Manipulation (UK BEAM) feasibility study
|
Farrin, Amanda |
|
2005 |
|
2 |
p. 119-124 |
artikel |
86 |
Discussion
|
Norton, Larry |
|
2007 |
|
2 |
p. 173-175 |
artikel |
87 |
Discussion
|
Ellenberg, Susan S. |
|
2007 |
|
2 |
p. 176-177 |
artikel |
88 |
Do antidepressants cause suicidality in children? A Bayesian meta-analysis
|
Kaizar, Eloise E |
|
2006 |
|
2 |
p. 73-98 |
artikel |
89 |
Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in children
|
Proschan, Michael A |
|
2010 |
|
2 |
p. 109-117 |
artikel |
90 |
Editorial: We may need large trials to find treatments for neurodegenerative diseases
|
Schoenfeld, David Alan |
|
|
|
2 |
p. 120-121 |
artikel |
91 |
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
|
Lai, Gabriel Y |
|
2006 |
|
2 |
p. 133-141 |
artikel |
92 |
Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial
|
Beauharnais, Catherine C |
|
2012 |
|
2 |
p. 198-203 |
artikel |
93 |
E-health data to support and enhance randomised controlled trials in the United Kingdom
|
Harron, Katie |
|
2015 |
|
2 |
p. 180-182 |
artikel |
94 |
Eliciting and using expert opinions about dropout bias in randomized controlled trials
|
White, Ian R |
|
2007 |
|
2 |
p. 125-139 |
artikel |
95 |
Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent
|
Yamal, Jose-Miguel |
|
2014 |
|
2 |
p. 187-194 |
artikel |
96 |
Equipoise: a case study of the views of clinicians involved in two neonatal trials
|
Garcia, Jo |
|
2004 |
|
2 |
p. 170-178 |
artikel |
97 |
Erratum
|
|
|
2005 |
|
2 |
p. 194-194 |
artikel |
98 |
Ethical concerns about adaptive randomization
|
Begg, Colin B |
|
2015 |
|
2 |
p. 101-101 |
artikel |
99 |
Ethical issues in HIV prevention research with people who inject drugs
|
Sugarman, Jeremy |
|
2014 |
|
2 |
p. 239-245 |
artikel |
100 |
Evaluating the safety of a rotavirus vaccine: the REST of the story
|
Heyse, Joseph F |
|
2008 |
|
2 |
p. 131-139 |
artikel |
101 |
Fallacies of last observation carried forward analyses
|
Lachin, John M |
|
2016 |
|
2 |
p. 161-168 |
artikel |
102 |
Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle
|
Dixon, Dennis |
|
2015 |
|
2 |
p. 179-179 |
artikel |
103 |
From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results
|
Cepeda, M Soledad |
|
2013 |
|
2 |
p. 347-348 |
artikel |
104 |
Harry Marks: an appreciation
|
Goodman, Steven N |
|
2011 |
|
2 |
p. 123-127 |
artikel |
105 |
Healthy Children, Strong Families 2: A randomized controlled trial of a healthy lifestyle intervention for American Indian families designed using community-based approaches
|
Tomayko, Emily J |
|
2017 |
|
2 |
p. 152-161 |
artikel |
106 |
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP
|
Lazar, Ann A |
|
2016 |
|
2 |
p. 169-179 |
artikel |
107 |
Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial
|
Duda, Catherine |
|
2011 |
|
2 |
p. 214-223 |
artikel |
108 |
Impact of individual clinical outcomes on trial participants’ perspectives on enrollment in emergency research without consent
|
Whitesides, Louisa W |
|
2017 |
|
2 |
p. 180-186 |
artikel |
109 |
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials
|
Kahn, Rebecca |
|
2018 |
|
2 |
p. 207-211 |
artikel |
110 |
Implementation of NIH inclusion guidelines: survey of NIH study section members
|
Taylor, Holly A |
|
2008 |
|
2 |
p. 140-146 |
artikel |
111 |
Implementing trials of complex interventions in community settings: The USC–Rancho Los Amigos Pressure Ulcer Prevention Study (PUPS)
|
Clark, Florence |
|
2014 |
|
2 |
p. 218-229 |
artikel |
112 |
IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies
|
Dampier, Carlton D |
|
2013 |
|
2 |
p. 319-331 |
artikel |
113 |
Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care
|
Eldridge, Sandra M |
|
2005 |
|
2 |
p. 91-98 |
artikel |
114 |
Integrating smoking cessation into mental health care for post-traumatic stress disorder
|
McFall, Miles |
|
2007 |
|
2 |
p. 178-189 |
artikel |
115 |
Investigational drug labeling variability
|
Duhamel, Amélie |
|
|
|
2 |
p. 204-213 |
artikel |
116 |
Issues in regulatory guidelines for data monitoring committees
|
DeMets, David |
|
2004 |
|
2 |
p. 162-169 |
artikel |
117 |
Key cost drivers of pharmaceutical clinical trials in the United States
|
Sertkaya, Aylin |
|
2016 |
|
2 |
p. 117-126 |
artikel |
118 |
Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans
|
Piana, Chiara |
|
2013 |
|
2 |
p. 269-279 |
artikel |
119 |
Landmark clinical trials: a new journal series
|
Goodman, Steven N |
|
2011 |
|
2 |
p. 128-128 |
artikel |
120 |
Lessons learned from an osteoporosis clinical trial in frail long-term care residents
|
Greenspan, SL |
|
2012 |
|
2 |
p. 247-256 |
artikel |
121 |
Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials
|
Larson, Gregg S |
|
2016 |
|
2 |
p. 127-136 |
artikel |
122 |
Letter to the Editor
|
Avins, Andrew |
|
2011 |
|
2 |
p. 238-238 |
artikel |
123 |
Listen to all the voices: an advocate's perspective on early access to investigational therapies
|
Mayer, Musa |
|
2006 |
|
2 |
p. 149-153 |
artikel |
124 |
Long-term drug prevention trials
|
Meinert, Curtis L |
|
2008 |
|
2 |
p. 168-176 |
artikel |
125 |
Maintaining confidentiality of interim data to enhance trial integrity and credibility
|
Fleming, Thomas R |
|
2008 |
|
2 |
p. 157-167 |
artikel |
126 |
Making the case for completion bonuses in clinical trials
|
Largent, Emily A |
|
|
|
2 |
p. 176-182 |
artikel |
127 |
Marvin Zelen, 1927–2014
|
Gelber, Richard D |
|
2015 |
|
2 |
p. 183-184 |
artikel |
128 |
Maximizing power and minimizing treatment failures in clinical trials
|
Rosenberger, William F |
|
2004 |
|
2 |
p. 141-147 |
artikel |
129 |
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone
|
Dahabreh, Issa J |
|
2008 |
|
2 |
p. 116-120 |
artikel |
130 |
Missing not at random models for masked clinical trials with dropouts
|
Kang, Shan |
|
2015 |
|
2 |
p. 139-148 |
artikel |
131 |
Monitoring futility in a two-by-two factorial design: The SPS3 experience
|
McClure, Leslie A |
|
2013 |
|
2 |
p. 250-256 |
artikel |
132 |
Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers
|
Carpenter, Matthew J |
|
2010 |
|
2 |
p. 157-166 |
artikel |
133 |
Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial
|
Eberly, Lynn E |
|
2004 |
|
2 |
p. 148-161 |
artikel |
134 |
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: Advancing the science of recruitment and breast cancer risk assessment in minority communities
|
McCaskill-Stevens, Worta |
|
2013 |
|
2 |
p. 280-291 |
artikel |
135 |
Network meta-analysis of randomized clinical trials: Reporting the proper summaries
|
Zhang, Jing |
|
2014 |
|
2 |
p. 246-262 |
artikel |
136 |
New challenges for 21st century clinical trials
|
Simon, Richard |
|
2007 |
|
2 |
p. 167-169 |
artikel |
137 |
On-site management of investigational products and drug delivery systems in conformity with Good Clinical Practices (GCPs)
|
Méthot, Julie |
|
2012 |
|
2 |
p. 265-271 |
artikel |
138 |
Organizational- and employee-level recruitment into a worksite-based weight loss study
|
Linnan, Laura |
|
2012 |
|
2 |
p. 215-225 |
artikel |
139 |
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial—design and methods
|
Wei, John |
|
2009 |
|
2 |
p. 162-171 |
artikel |
140 |
Overlap coefficient for assessing the similarity of pharmacokinetic data between ethnically different populations
|
Mizuno, Sachiko |
|
2005 |
|
2 |
p. 174-181 |
artikel |
141 |
Personal reflections on lessons learned from randomized trials involving newborn infants from 1951 to 1967
|
Silverman, William A. |
|
2004 |
|
2 |
p. 179-184 |
artikel |
142 |
Planning and core analyses for periodic aggregate safety data reviews
|
Xia, H Amy |
|
2011 |
|
2 |
p. 175-182 |
artikel |
143 |
PRagmatic trial Of Video Education in Nursing homes: The design and rationale for a pragmatic cluster randomized trial in the nursing home setting
|
Mor, Vincent |
|
2017 |
|
2 |
p. 140-151 |
artikel |
144 |
Prediction of event times in the REMATCH Trial
|
Ying, Gui-Shuang |
|
2013 |
|
2 |
p. 197-206 |
artikel |
145 |
Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials
|
Turner, Rebecca M |
|
2005 |
|
2 |
p. 108-118 |
artikel |
146 |
Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
|
Julien, Marilyse |
|
2008 |
|
2 |
p. 107-115 |
artikel |
147 |
Quality assurance of research protocols conducted in the community: The National Institute on Drug Abuse Clinical Trials Network Experience
|
Rosa, Carmen |
|
2009 |
|
2 |
p. 151-161 |
artikel |
148 |
Randomization inference for balanced cluster-randomized trials
|
Raab, Gillian M |
|
2005 |
|
2 |
p. 130-140 |
artikel |
149 |
Randomized controlled trial of Nuevo Amanecer: A peer-delivered stress management intervention for Spanish-speaking Latinas with breast cancer
|
Nápoles, Anna M |
|
2014 |
|
2 |
p. 230-238 |
artikel |
150 |
Randomized trials of alcohol-use interventions with college students and their parents: lessons from the Transitions Project
|
Fernandez, AC |
|
2011 |
|
2 |
p. 205-213 |
artikel |
151 |
Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture
|
Rua, Tiago |
|
2018 |
|
2 |
p. 120-129 |
artikel |
152 |
Recruiting and retaining young adults in a weight gain prevention trial: Lessons learned from the CHOICES study
|
Moe, Stacey G |
|
2016 |
|
2 |
p. 205-213 |
artikel |
153 |
Recruiting Chinese Americans into cancer screening intervention trials: Strategies and outcomes
|
Wang, Judy Huei-yu |
|
2014 |
|
2 |
p. 167-177 |
artikel |
154 |
Recruiting community health centers into pragmatic research: Findings from STOP CRC
|
Coronado, Gloria D |
|
2016 |
|
2 |
p. 214-222 |
artikel |
155 |
Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective
|
Franciscus, Margaret |
|
2014 |
|
2 |
p. 150-158 |
artikel |
156 |
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience
|
Bhanushali, Minal J |
|
2014 |
|
2 |
p. 159-166 |
artikel |
157 |
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial
|
Dew, Alexander |
|
2013 |
|
2 |
p. 292-299 |
artikel |
158 |
Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: The Breastfeeding, Antiretrovirals and Nutrition study experience
|
Sellers, Christopher J |
|
2015 |
|
2 |
p. 156-165 |
artikel |
159 |
Reducing selection bias in a cluster randomized trial in West African villages
|
Kerry, Sally M |
|
2005 |
|
2 |
p. 125-129 |
artikel |
160 |
Reflections on Professor Jerome Cornfield’s contributions to the US Food and Drug Administration
|
O’Neill, Robert T |
|
2013 |
|
2 |
p. 332-336 |
artikel |
161 |
Regional differences in multinational clinical trials: anticipating chance variation
|
Marschner, Ian C |
|
2010 |
|
2 |
p. 147-156 |
artikel |
162 |
Rejoinder
|
Fleming, Thomas R |
|
2017 |
|
2 |
p. 126-127 |
artikel |
163 |
Rejoinder
|
Hey, Spencer Phillips |
|
2015 |
|
2 |
p. 125-127 |
artikel |
164 |
Reminiscences of Jerry Cornfield
|
Lachin, John M |
|
2013 |
|
2 |
p. 337-339 |
artikel |
165 |
Response
|
Kahn, Susan R |
|
2015 |
|
2 |
p. 178-178 |
artikel |
166 |
Response to Chappell
|
Vickers, Andrew J |
|
|
|
2 |
p. 216 |
artikel |
167 |
Response to commentary
|
Proshan, Michael A |
|
2010 |
|
2 |
p. 120-120 |
artikel |
168 |
Response to Magnus and Wilfond
|
Kim, Scott YH |
|
2016 |
|
2 |
p. 244-245 |
artikel |
169 |
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
|
Karrison, Theodore |
|
2018 |
|
2 |
p. 178-188 |
artikel |
170 |
Reverse-Bayes analysis of two common misinterpretations of significance tests
|
Held, Leonhard |
|
2013 |
|
2 |
p. 236-242 |
artikel |
171 |
Review: An examination of effect estimation in factorial and standardly-tailored designs
|
Allore, Heather G |
|
2008 |
|
2 |
p. 121-130 |
artikel |
172 |
Risks of phase I research with healthy participants: A systematic review
|
Johnson, Rebecca A |
|
2016 |
|
2 |
p. 149-160 |
artikel |
173 |
Routine data from hospital information systems can support patient recruitment for clinical studies
|
Dugas, Martin |
|
2010 |
|
2 |
p. 183-189 |
artikel |
174 |
Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of Family Therapy vs. Treatment as Usual in adolescents following self-harm
|
Wright-Hughes, Alexandra |
|
2018 |
|
2 |
p. 197-206 |
artikel |
175 |
Routinely collected data for trialists: The need for continued conversations and solution sharing
|
Lugg-Widger, Fiona V |
|
|
|
2 |
p. 217-218 |
artikel |
176 |
Sample size under the additive hazards model
|
McDaniel, Lee S |
|
2016 |
|
2 |
p. 188-198 |
artikel |
177 |
SCT 32nd Annual Meeting, May 15–18, 2011 – Vancouver, British Columbia, Canada
|
|
|
2011 |
|
2 |
p. 239-241 |
artikel |
178 |
Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
|
Weisberg, Herbert I |
|
2009 |
|
2 |
p. 109-118 |
artikel |
179 |
Sequential meta-analysis: an efficient decision-making tool
|
van der Tweel, Ingeborg |
|
2010 |
|
2 |
p. 136-146 |
artikel |
180 |
Should consent forms used in clinical trials be translated into the local dialects? A survey among past participants in rural Ghana
|
Baiden, Frank |
|
2016 |
|
2 |
p. 234-239 |
artikel |
181 |
Simultaneously optimizing dose and schedule of a new cytotoxic agent
|
Braun, Thomas M. |
|
2007 |
|
2 |
p. 113-124 |
artikel |
182 |
Society for Clinical Trials
|
|
|
2006 |
|
2 |
p. 165-247 |
artikel |
183 |
Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis
|
White, Ian R |
|
2005 |
|
2 |
p. 141-151 |
artikel |
184 |
Stopping clinical trials early for benefit: impact on estimation
|
Freidlin, Boris |
|
2009 |
|
2 |
p. 119-125 |
artikel |
185 |
Stopping trials for efficacy: an almost unbiased view
|
Goodman, Steven N |
|
2009 |
|
2 |
p. 133-135 |
artikel |
186 |
Strength of evidence for labeled dosing recommendations in renal impairment
|
Gagne, Joshua J |
|
2017 |
|
2 |
p. 219-221 |
artikel |
187 |
Suspension of accrual in phase II cancer clinical trials
|
Li, Yimei |
|
2015 |
|
2 |
p. 128-138 |
artikel |
188 |
Targeted therapy in oncology
|
Begg, Colin B. |
|
2007 |
|
2 |
p. 162-162 |
artikel |
189 |
Target practice: oncology drug development in the era of genomic medicine
|
Schilsky, Richard L. |
|
2007 |
|
2 |
p. 163-166 |
artikel |
190 |
25 th Annual Meeting of the Society for Clinical Trials Hyatt Regency Hotel, New Orleans, Louisiana Full Conference
|
|
|
2004 |
|
2 |
p. 194-207 |
artikel |
191 |
25 th Annual Meeting of the Society for Clinical Trials Hyatt Regency Hotel, New Orleans, Louisiana Preconference Workshops
|
|
|
2004 |
|
2 |
p. 191-193 |
artikel |
192 |
The calibration of treatment effects from clinical trials to target populations
|
Frangakis, Constantine |
|
2009 |
|
2 |
p. 136-140 |
artikel |
193 |
The design and conduct of Project RedDE: A cluster-randomized trial to reduce diagnostic errors in pediatric primary care
|
Bundy, David G |
|
|
|
2 |
p. 154-164 |
artikel |
194 |
The effect of heterogeneity on HIV prevention trials
|
Auvert, Bertran |
|
2011 |
|
2 |
p. 144-154 |
artikel |
195 |
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era
|
Mocroft, A |
|
2006 |
|
2 |
p. 119-132 |
artikel |
196 |
The impact of registration of clinical trials units: The UK experience
|
McFadden, Eleanor |
|
2015 |
|
2 |
p. 166-173 |
artikel |
197 |
The (in)stability of 21st century orthopedic patient contact information and its implications on clinical research: A cross-sectional study
|
London, Daniel A |
|
2017 |
|
2 |
p. 187-191 |
artikel |
198 |
The net effect of alternative allocation ratios on recruitment time and trial cost
|
Vozdolska, Ralitza |
|
2009 |
|
2 |
p. 126-132 |
artikel |
199 |
The Positive Emotions after Acute Coronary Events behavioral health intervention: Design, rationale, and preliminary feasibility of a factorial design study
|
Huffman, Jeffery C |
|
2017 |
|
2 |
p. 128-139 |
artikel |
200 |
The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial
|
Bakobaki, Julie M |
|
2012 |
|
2 |
p. 257-264 |
artikel |
201 |
The 1954 Salk poliomyelitis vaccine field trial
|
Marks, Harry M |
|
2011 |
|
2 |
p. 224-234 |
artikel |
202 |
The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients
|
|
|
2006 |
|
2 |
p. 154-157 |
artikel |
203 |
The Society for Clinical Trials supports United States legislation mandating trials registration
|
Rockhold, Frank |
|
2005 |
|
2 |
p. 193-193 |
artikel |
204 |
The use and reporting of patient-reported outcomes in phase III breast cancer trials
|
Brim, Remy L |
|
2013 |
|
2 |
p. 243-249 |
artikel |
205 |
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease
|
Pritchett, Yili |
|
2011 |
|
2 |
p. 165-174 |
artikel |
206 |
The use of random effects models to allow for clustering in individually randomized trials
|
Lee, Katherine J |
|
2005 |
|
2 |
p. 163-173 |
artikel |
207 |
Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials
|
Kim, Haesook Teresa |
|
2012 |
|
2 |
p. 155-163 |
artikel |
208 |
Translational clinical trials: an entropy-based approach to sample size
|
Piantadosi, Steven |
|
2005 |
|
2 |
p. 182-192 |
artikel |
209 |
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
|
Jaki, Thomas |
|
2013 |
|
2 |
p. 344-346 |
artikel |
210 |
Use of online recruitment strategies in a randomized trial of cancer survivors
|
Juraschek, Stephen P |
|
2018 |
|
2 |
p. 130-138 |
artikel |
211 |
Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial
|
Balzer, Laura |
|
2017 |
|
2 |
p. 201-210 |
artikel |
212 |
Using factor analysis to confirm the validity of children's self-reported health-related quality of life across different modes of administration
|
Varni, James W |
|
2009 |
|
2 |
p. 185-195 |
artikel |
213 |
Variance prior specification for a basket trial design using Bayesian hierarchical modeling
|
Cunanan, Kristen M |
|
|
|
2 |
p. 142-153 |
artikel |
214 |
What can we learn from a decade of database audits? The Duke Clinical Research Institute experience, 1997—2006
|
Rostami, Reza |
|
2009 |
|
2 |
p. 141-150 |
artikel |